Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT

Biological Psychiatry

Volumn 54, Issue 8, 2003, Pages 792-799

  Kugaya, Akira ^a,e   Sanacora, Gerard ^a   Verhoeff, Nicolaas P L G ^a   Fujita, Masahiro ^a   Mason, Graeme F ^a,c   Seneca, Nicholas M ^a   Bozkurt, Ali ^a   Khan, Shaukat A ^a   Anand, Amit ^a   Degen, Kathleen ^a   Charney, Dennis S ^a   Zoghbi, Sami S ^a   Baldwin, Ronald M ^a   Seibyl, John P ^a,b,d   Innis, Robert B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c Yale University   (United States)

^d Inst for Neurodeg Disorders   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Benzodiazepine receptor; GABA; Iomazenil; Major depression; MRS; SPECT

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE RECEPTOR; IOMAZENIL I 123; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; GRAY MATTER; HUMAN; MAJOR DEPRESSION; MALE; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 10744229095     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01788-2     Document Type: Article

References (51)

1. Abi-Dargham A., Gandelman M., Zoghbi S.S., Laruelle M., Baldwin R.M., Randoll P., et al. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. J Nucl Med. 36:1995;167-175.
2. 123I].
3. Abi-Dargham A., Laruelle M., Krystal J., D'Souza C., Zoghbi S., Baldwin R.M., et al. No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia. Neuropsychopharmacology. 20:1999;650-661.
4. 123I]iomazenil Kinetic and equilibrium paradigms . J Nucl Med. 35:1994;228-238.
5. A receptors. International Rev Neurobiol. 39:1996;53-76.
6. 3H].
7. Bremner J., Narayan M., Anderson E., Staib L., Miller H., Charney D. Hippocampal volume reduction in major depression. Am J Psychiatry. 157:2000;115-118.
8. 123I]iomazenil measurement of benzodiazepine receptors in panic disorder. Biol Psychiatry. 47:2000;96-106.
9. A/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res. 460:1988;114-123.
10. Coffey C., Wilkinson W., Weiner R., Parashos I., Djang W., Webb M., et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry. 50:1993;7-16.
11. Craig C., Colasanti B. GABA receptors, lipids, and gangliosides in cobalt epileptic focus. Adv Neurol. 44:1986;379-391.
12. Crow T., Cross A., Cooper S., Deakin J., Ferrier I., Johnson J., et al. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology. 23:1984;1561-1569.
13. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
14. Drugan R.C., Morrow A.L., Weizman R., Weizman A., Deutsch S.I., Crawley J.N., et al. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res. 487:1989;45-51.
15. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders. Patient Edition: 1995;Biometric Research Department, New York State Psychiatric Institute, New York.
16. Friston K., Worsley K., Frackowiack R., Mazziotta J., Evans A. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapping. 1:1994;210-220.
17. Friston K.J., Holmes A.P., Worsley K.J., Poline J.-P., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging A general linear approach . Hum Brain Mapping. 2:1995;189-210.
18. Fujita M., Woods S.W., Verhoeff N.P.L.G., Abi-Dargham A., Baldwin R.M., Zoghbi S.S., et al. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans. Eur J Pharmacol. 368:1999;161-172.
19. Gerner R., Fairbanks L., Anderson M., Young J., Scheinin M., Linnoila M., et al. CSF neurochemistry in depressed, manic and schizophrenic patients compared with normal controls. Am J Psychiatry. 141:1984;1540-1553.
20. Gerner R., Hare T. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry. 138:1981;1098-1101.
21. Gold B., Bowers M., Roth R., Sweeney D. GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry. 137:1980;362-364.
22. Halbreich U., Petty F., Yonkers K., Kramer G., Rush A., Bibi K. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorders. Am J Psychiatry. 153:1996;718-720.
23. Johnson E.W., Woods S.W., Zoghbi S., Baldwin R., Innis R.B. Characterization of the benzodiazepine radioligand 125I-Ro16-0154 Potential probe for SPECT brain imaging . Life Sci. 47:1990;1535-1546.
24. Kasa K., Otsuki S., Yamamoto M., Sato M., Kuroda H., Ogawa N. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Biol Psychiatry. 17:1982;877-883.
25. Kram M.L., Kramer G.L., Steciuk M., Ronan P.J., Petty F. Effects of learned helplessness on brain GABA receptors. Neurosci Res. 38:2000;193-198.
26. Krishnan K.R.R., McDonald W.M., Escalona P.R., Doraiswamy P.M., Na C., Husain M.M., et al. Magentic resonance imaging of the caudate nuclei in depression Preliminary observations . Arch Gen Psychiatry. 49:1992;553-557.
27. Manchon M., Kopp N., Rouzioux J., Lecestre D., Deluermoz S., Miachon S. Benzodiazepine receptor and neurotransmitter studies in the brain of suicides. Life Sci. 41:1987;2623-2630.
28. Mohler H., Burkard W., Keller H., Richards J., Haefely W. Benzodiazepine antagonist Ro 15-1788 Binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels . J Neurochem. 37:1981;714-722.
29. A receptors. FASEB J. 4:1990;1469-1480.
30. Pandey G., Conley R., Pandey S., Goel S., Roberts R., Tamminga C., et al. Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects. Psychiatry Res. 71:1997;137-149.
31. Petty F., Kramer G., Dunnam D., Rush A. Plasma GABA in mood disorders. Psychopharmacol Bull. 26:1990;157-161.
32. Rajeevan N., Zubal I.G., Ramsby S.Q., Zoghbi S.S., Seibyl J., Innis R.B. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. J Nucl Med. 39:1998;1719-1726.
33. Richardson M., Friston K., Sisodiya S., Koepp M., Ashburner J., Free S., et al. Cortical grey matter and benzodiazepine receptors in malformation of cortical development. A voxel-based comparison of structural and functional imaging data. Brain. 120:1997;1961-1973.
34. Rochet T., Kopp N., Vedrinne J., Deluermoz S., Debilly G., Miachon S. Benzodiazepine binding sites and their modulators in hippocampus of violent suicide victims. Biol Psychiatry. 32:1992;922-931.
35. Rothman D.L., Behar K.L., den Hetherington H.P., Bendall M.R., Petroff O.A., Shulman R.G. 1H Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo. Proc Natl Acad Sci U S A. 82:1985;1633-1637.
36. Sanacora G., Mason G., Rothman D., Behar K., Hyder F., Petroff O., et al. Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 56:1999;1043-1047.
37. Shah P., Ebmeier K., Glabus M., Goodwin G. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Br J Psychiatry. 172:1998;527-532.
38. Sheline Y. 3D MRI studies of neuroanatomic changes in unipolar major depression The role of stress and medical comorbidity . Biol Psychiatry. 48:2000;791-800.
39. Sheline Y., Gado M., Price J. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport. 22:1998;2023-2028.
40. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 93:1996;3908-3913.
41. Sisodiya S., Free S., Stevens J., Fish D., Shorvon S. Widespread cerebral structural changes in patients with cortical dysgenesis and epilepsy. Brain. 118:1995;1039-1050.
42. Soares J., Mann J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry. 41:1997;86-106.
43. Spitzer R., Williams J., Gibbon M., First M. Structured Clinical Interview for DSM-III-R-Non-Patient Edition (SCID-NP, Ver 1.0). 1990;American Psychiatric Press, Washington, DC.
44. Stocks G., Cheetham S., Crompton M., Katona C., Horton R. Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims. J Affective Disorder. 18:1990;11-15.
45. Tallman J., Thomas J., Gallager D. GABAergic modulation of benzodiazepine binding site sensitivity. Nature. 274:1978;383-385.
46. Tallman J.F., Gallager D.W. The GABA-ergic system A locus of benzodiazepine action . Ann Rev Neurosci. 8:1985;21-44.
47. 123I]iomazenil SPECT and GABA MRS. Epilepsia. 40:1999;1433-1438.
48. 123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Res Neuroimaging. 91:1999;163-173.
49. A benzodiazepine receptors in the mouse. Brain Res. 519:1990;347-350.
50. Wright I., McGuire P., Poline J., Travere J., Murray R., Frith C., et al. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage. 2:1995;244-252.
51. 123I]iomazenil in human and nonhuman primates. Nucl Med Biol. 19:1992;881-888.